| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/07/2002 | US20020028247 Micro-particulate form of a tetrahydropyridin derivative |
| 03/07/2002 | US20020028246 Neutral support grain coated with a mixture of morphine sulfate and of a binder, such as hydroxypropylmethylcellulose; immediate-release |
| 03/07/2002 | US20020028245 Compact member, method of manufacturing and use thereof |
| 03/07/2002 | US20020028244 Biodegradable neurotoxin implant |
| 03/07/2002 | US20020028243 Protein matrix materials, devices and methods of making and using thereof |
| 03/07/2002 | US20020028242 Paroxetine controlled release compositions |
| 03/07/2002 | US20020028241 Heat treating polymer mixture of a natural or synthetic polycarboxylated polymer and at least one polysaccharide to effect crosslinking |
| 03/07/2002 | US20020028240 Timed-release compression-coated solid composition for oral administration |
| 03/07/2002 | US20020028239 Tablet composition |
| 03/07/2002 | US20020028238 Orally administration to provide a blood plasma concentration profile of celecoxib of at least about 250 mg/ml in not more than about 30 minutes |
| 03/07/2002 | US20020028237 Method for reducing toxicity of a cytotoxic agent |
| 03/07/2002 | US20020028236 Erythropoietin or derivatives that cause bone marrow cells to increase production of reticulocytes and erythrocytes; hydrogenated lecithin that may be hydrogenated; cholesterol or a derivative; phosphate buffer |
| 03/07/2002 | US20020028235 Dermal penetration enhancer is a safe skin-tolerant ester sunscreen. |
| 03/07/2002 | US20020028234 Especially medicaments containing verapamil; a lecithin/isopropyl myristate solution; butylated hydroxy toluene; pluronic F127; an antioxidant agent suspended in a carrier |
| 03/07/2002 | US20020028230 Composition containing moisture regulators for tissue products, process for the production of these products, use of the composition for the treatment of tissue products as well as tissue products in the form of wet-laid, including TAD, or air-laid products (non-wovens) on the basis of sheet-like support materials containing primarily cellulose fibers |
| 03/07/2002 | US20020028219 Novel liposome complexes for increased systemic delivery |
| 03/07/2002 | US20020028218 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 03/07/2002 | US20020028216 Controlled release implantable drug delivery system composed of a plurality of botulinum toxin-incorporating polymeric microspheres. |
| 03/07/2002 | US20020028212 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 03/07/2002 | US20020028201 Element A, which is a plastic with a group derived from a carboxy acid (e.g., an acrylate polymer), is hydrogen bonded to an element B (e.g., polyalkylene glycol; coupling physiologically and/or pharmacologically active substances |
| 03/07/2002 | US20020028183 Medicaments |
| 03/07/2002 | US20020028181 Polyacid/polyalkylene oxide foams and gels and methods for their delivery |
| 03/07/2002 | US20020028180 Particles treated so as to dislodge small grains from the surface of the particles, without substantially changing the size of the particles |
| 03/07/2002 | US20020026886 Useful for coloring of food products and pharmaceuticals do not migrate in products and they are acid stable; are useful in coating formulations for tablets and dragees |
| 03/07/2002 | US20020026771 Method of encapsulation |
| 03/07/2002 | DE10040610A1 Flavonhaltige Pflanzenextraktlösungen mit verbesserter Lager- und Hitzestabilität Flavonhaltige plant extract solutions with improved storage and heat stability |
| 03/07/2002 | DE10040592A1 Composition for oral administration of drugs, e.g. peptidomimetics or sparingly soluble antibiotics, containing hydrogel copolymer of unsaturated acid and polyalkylene glycol ester as resorption improver |
| 03/07/2002 | CA2746787A1 Method of increasing testosterone and related steroid concentrations in women |
| 03/07/2002 | CA2425367A1 Oct formulations |
| 03/07/2002 | CA2421503A1 Methods and compositions for inhibiting angiogenesis |
| 03/07/2002 | CA2420804A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | CA2420600A1 Pectin film compositions |
| 03/07/2002 | CA2420569A1 Use of threo-methylphenidate compounds to enhance memory |
| 03/07/2002 | CA2420545A1 Apparatus for treatment of chronic obstructive pulmonary disease and associated method |
| 03/07/2002 | CA2420535A1 Sustained release formulations for growth hormone secretagogues |
| 03/07/2002 | CA2420532A1 Pharmaceutical formulation of salmeterol and fluticasone propionate |
| 03/07/2002 | CA2420518A1 Clear antiperspirants and deodorants made with siloxane-based polyamides |
| 03/07/2002 | CA2419935A1 Collagen/polysaccharide bilayer matrix |
| 03/07/2002 | CA2419606A1 Lung surfactant compositions with dynamic swelling behaviour |
| 03/07/2002 | CA2419249A1 Water-dispersible encapsulated sterols |
| 03/07/2002 | CA2418038A1 Paroxetine compositions and processes for making the same |
| 03/06/2002 | EP1184038A1 System for release in lower digestive tract |
| 03/06/2002 | EP1184034A2 Oral drug composition containing a verapamil derivative as a drug-absorption promotor |
| 03/06/2002 | EP1184033A1 Pectin film compositions |
| 03/06/2002 | EP1184032A1 Dextran hydrogels |
| 03/06/2002 | EP1183954A1 Fading inhibitors |
| 03/06/2002 | EP1183538A1 Cyclodextrin polymers for use as drug carriers |
| 03/06/2002 | EP1183384A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 03/06/2002 | EP1183358A1 Targeted angiogenesis |
| 03/06/2002 | EP1183302A1 Controlled release polyacrylic acid granules and a process for preparing the same |
| 03/06/2002 | EP1183275A2 Combined approach to treatment of cancer with hcg vaccines |
| 03/06/2002 | EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/06/2002 | EP1183231A1 Cytofectin dimers and methods of use thereof |
| 03/06/2002 | EP1183228A2 Esters of l-carnitine or alkanoyl l-carnitines |
| 03/06/2002 | EP1183157A1 Device for applying an adhesive skin tattoo and for administering a pharmaceutical and/or cosmetic product |
| 03/06/2002 | EP1183045A2 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response |
| 03/06/2002 | EP1183043A2 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors |
| 03/06/2002 | EP1183039A1 Pharmaceutical preparations of bioactive substances extracted from natural sources |
| 03/06/2002 | EP1183030A1 Methods of making and using n-desmethylzopiclone |
| 03/06/2002 | EP1183029A2 Pharmaceutical preparation containing the active substance diamorphine and its utilization in a method for treating opiate addiction |
| 03/06/2002 | EP1183027A1 Pharmaceutical formulations and methods comprising intranasal morphine |
| 03/06/2002 | EP1183026A2 Improved pharmaceutical formulations |
| 03/06/2002 | EP1183022A1 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
| 03/06/2002 | EP1183018A1 Methods for coating particles and particles produced thereby |
| 03/06/2002 | EP1183017A1 Novel formulations comprising lipid-regulating agents |
| 03/06/2002 | EP1183016A1 Stereocomplex hydrogels |
| 03/06/2002 | EP1183015A1 Multilayered tablet for administration of a fixed combination of tramadol and diclofenac |
| 03/06/2002 | EP1183014A1 Controlled release and taste masking oral pharmaceutical compositions |
| 03/06/2002 | EP1183013A2 Melt granulation |
| 03/06/2002 | EP1183012A1 Novel formulations comprising lipid-regulating agents |
| 03/06/2002 | EP1183011A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto |
| 03/06/2002 | EP1183010A2 Implantable gel compositions and method of manufacture |
| 03/06/2002 | EP1183009A1 Acidic buffered nasal spray |
| 03/06/2002 | EP1183005A1 After shave composition containing aluminum chlorohydrate |
| 03/06/2002 | EP1182931A1 Stable biocidal compositions |
| 03/06/2002 | EP1182929A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues |
| 03/06/2002 | EP1182927A1 Antimicrobial sanitizing lotion with skin protection properties |
| 03/06/2002 | EP1096944B1 Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 03/06/2002 | EP1069891B1 Wettable microcapsules having ethylcellulose coated cores |
| 03/06/2002 | EP1032378B1 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
| 03/06/2002 | EP0961602B1 Contour of a transdermal therapeutic system |
| 03/06/2002 | EP0958043B1 An apparatus and a method for treating particulate materials |
| 03/06/2002 | EP0946150B1 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium |
| 03/06/2002 | EP0942743B1 Topical preparation for introducing peptidaceous pharmacons in living organisms |
| 03/06/2002 | EP0896529B1 Estradiol and progesterone-based medicament |
| 03/06/2002 | EP0873133B1 Biologically active composition comprising cyclosporine |
| 03/06/2002 | EP0845999B1 Method for the production of tablets by pressing and tablets produced by the method |
| 03/06/2002 | EP0835105B1 Pharmaceutical amiodarone composition for parenteral delivery |
| 03/06/2002 | EP0825854B1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 03/06/2002 | EP0790822B1 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure |
| 03/06/2002 | EP0785797B1 A pharmaceutical formulation comprising a growth hormone and leucine |
| 03/06/2002 | EP0754045B1 compositions comprising halofantrine in a special form |
| 03/06/2002 | EP0734257B1 Pharmaceutical compositions for topical use containing (s)-2-(4-isobutylphenyl)propionic acid |
| 03/06/2002 | EP0613371B1 New combination of formoterol and budesonide |
| 03/06/2002 | CN2479952Y Nm silver plaster for trauma |
| 03/06/2002 | CN1339034A Potassium salt of (I(S))-omeprazole |
| 03/06/2002 | CN1338956A Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor |
| 03/06/2002 | CN1338948A Sustained release implant, methods for preparation thereof and for treating cancer |
| 03/06/2002 | CN1338947A Novel mucosal delivery system |
| 03/06/2002 | CN1338942A Self-emulsifying compositions for drugs poorly soluble in water |